Boston, MA -- (SBWIRE) -- 08/17/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: Pfizer Inc. (NYSE:PFE), Johnson & Johnson (NYSE:JNJ), Merck & Co., Inc. (NYSE:MRK), Bristol-Myers Squibb Co (NYSE:BMY)
Pfizer Inc. (NYSE:PFE) closed yesterday at $28.37, down -1.49%, on volume of over 28.27 million shares. PFE fell -2.88% in the last 5 days. PFE average trading volume is 28.27 million shares.In the time frame of the last one month, shares of Pfizer dropped Almost -1.08%. Its market capitalization was $187.82 billion. Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. The Company manages its operations through five segments: Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health and Consumer Healthcare, and Nutrition.
Has PFE Found The Bottom and Ready To Move Up? Find Out Here
Johnson & Johnson (NYSE:JNJ) ended previous trading at $89.37, losing -0.20%, with almost 14.10 million shares traded. In the last 5 days JNJ showed a drop of -3.24% and on its one month graph, shares of JNJ are -1.14% down. The stock has a 52-week high price of $94.42 and its 52-week low was recorded at $66.85. Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a broad range of products in the health care field. The business of Johnson & Johnson is conducted by more than 275 operating companies located in 60 countries, including the United States,
Has JNJ Found The Bottom And Ready To Gain Momentum? Find Out Here
Merck & Co., Inc. (NYSE:MRK) finished trading previously at $47.70, losing -0.56%. Trading volume recorded almost 13.20 million shares as compared to its average volume of 10.82 million shares.Shares of MRK declined almost -1.1% in the last one month while its 52 week high is $50.16. MRK has the total of 2.93 billion outstanding shares while its market capitalization was $139.59 billion. Merck & Co., Inc. (Merck) is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures.
Why Should Investors Buy MRK After the Recent Fall? Just Go Here and Find Out
Bristol-Myers Squibb Co (NYSE:BMY) closed yesterday at $41.68, down -0.71%, on volume of over 8.49 million shares. BMY fell -4.6% in the last 5 days. BMY average trading volume is 7.02 million shares. In the time frame of the last one month, shares of Bristol-Myers Squibb dropped Almost -7.36%. Its market capitalization was $68.62 billion. Bristol-Myers Squibb Company (BMS) is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. It operates in BioPharmaceuticals.
Will BMY Get Buyers Even After The Recent Rally? Find Out Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)